fruquintinib

FDA Approves Fruzaqla in Refractory Metastatic Colorectal Cancer

The FDA approved fruquintinib (Fruzaqla, Takeda) for some previously treated adults with metastatic colorectal ...

NOVEMBER 15, 2023

Load more